Arrhythmogenic threshold of the myocardium under conditions of magnesium deficiency

  • A. A. Spasov
  • I. N. Iezhitsa
  • M. V. Kharitonova
  • N. A. Gurova
Pharmacology and Toxicology

We studied the arrhythmogenic threshold of the myocardium after injection of CaCl2 to magnesium-deficient rats receiving Mg2+ L-aspartate, MgCl2, their combination with vitamin B6, and reference preparations Magne B6® and MgSO4 until complete compensation of magnesium level in the plasma and erythrocytes. Magnesium-deficient diet and deionized water were used for inducing alimentary Mg2+ deficiency and modeling pathological changes in rats. After reducing Mg2+ level to 0.7 mmol/liter in the plasma and to 1.5 mmol/liter in erythrocytes, Mg L-aspartate, MgCl2, their combination with vitamin B6, as well as Mg2+ deficiency led to a decrease in the dose of CaCl2 provoking heart rhythm disturbances in 50% animals and shortening of animal life span. Administration of the test magnesium salts increased the arrhythmogenic threshold; Mg2+ salts were comparable by their efficiency with Magne B6® and were far superior to MgSO4.

Key Words

magnesium deficiency arrhythmia calcium chloride magnesium pyridoxine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A. A. Spasov, Magnesium in Medical Practice [in Russian], Volgograd (2000).Google Scholar
  2. 2.
    A. A. Spasov, I. N. Iezhitsa, N. V. Zhuravleva, et al., Kardiologiya, 46, No. 7, 62–65 (2006).Google Scholar
  3. 3.
    M. Firoz and M. Graber, Magnes. Res. 14, No. 4, 257–262 (2001).PubMedGoogle Scholar
  4. 4.
    S. Ichikawa, Jpn. J. Thorac. Cardiovasc. Surg., 46, No. 3, 287–298 (1998).PubMedGoogle Scholar
  5. 5.
    I. N. Iezhitsa, A. A. Spasov, M. S. Kravchenko, et al., J. Jpn. Soc. Magnes. Res., 25, No. 2, 99 (2006).Google Scholar
  6. 6.
    L. M. Klevay and D. B. Milne, Am. J. Clin. Nutr., 75, No. 3, 550–554 (2002).PubMedGoogle Scholar
  7. 7.
    C. Meenagh, C. Mulholland, and M. F. Ryan, J. Psychopharmacol., 8, No. 3, 438–439 (2004).CrossRefGoogle Scholar
  8. 8.
    A. Tsuji, K. Araki, K. Maeyama, and Ê. Hashimoto, J. Cardiovasc. Pharmacol. Ther., 10, No. 3, 205–208 (2005).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2008

Authors and Affiliations

  • A. A. Spasov
    • 1
  • I. N. Iezhitsa
    • 1
  • M. V. Kharitonova
    • 1
  • N. A. Gurova
    • 1
  1. 1.Institute of Pharmacology; Department of PharmacologyVolgograd State Medical UniversityVolgogradRussia

Personalised recommendations